Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Metaplastic Breast Cancer Global Alliance is a 501(c)(3) non-profit organization dedicated to supporting patients diagnosed with metaplastic breast cancer (MpBC), a rare and aggressive subtype of breast cancer. The organization focuses on three primary pillars: patient support, education, and the advancement of medical research. By partnering with clinicians and researchers, the Alliance aims to identify more effective treatments and eventually a cure for MpBC. They provide resources for patients to navigate their diagnosis and facilitate a global community for those affected by this rare disease. Additionally, the Alliance actively funds research initiatives and promotes the development of patient registries to better understand the biology of the disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metaplastic Breast Cancer Global Alliance.